Abstract
HPR2 Addressing Legislative and Financial Hurdles in Rare Disease Medicines Accessibility: Insight From Czechia With a Focus on the Pediatric Population
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have